David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNACU
1401
DELISTED
Constellation Alpha Capital Corp. Unit
CNACU
| $4.62M | 0.01% |
450,000
| – | – |
|
1402
Calix
CALX
$2.51B
| $4.62M | 0.01% |
914,444
+11,958
| +1% | +$68.3K |
|
1403
CALL
Under Armour
UAA
$2.2B
| $4.61M | 0.01% |
280,000
+90,000
| +47% | +$1.65M |
|
1404
Ironwood Pharmaceuticals
IRWD
$725M
| $4.6M | 0.01% |
348,477
+44,025
| +14% | +$606K |
|
|
NXTM
1405
DELISTED
NxStage Medical Inc.
NXTM
| $4.6M | 0.01% |
166,774
-64,489
| -28% | -$1.72M |
|
1406
CALL
Align Technology
ALGN
$11.3B
| $4.58M | 0.01% |
24,600
+3,400
| +16% | +$582K |
|
1407
Beazer Homes USA
BZH
$885M
| $4.58M | 0.01% |
244,479
-99,145
| -29% | -$1.51M |
|
1408
Paylocity
PCTY
$8.08B
| $4.58M | 0.01% |
93,828
-13,293
| -12% | -$617K |
|
1409
Exponent
EXPO
$3.33B
| $4.58M | 0.01% |
123,930
-23,670
| -16% | -$782K |
|
|
ARC
1410
DELISTED
ARC Document Solutions, Inc.
ARC
| $4.58M | 0.01% |
1,119,558
-3,455
| -0.3% | -$13.1K |
|
|
CARB
1411
DELISTED
Carbonite Inc
CARB
| $4.57M | 0.01% |
207,823
-150,873
| -42% | -$3.19M |
|
|
MPT
1412
Medical Properties Trust
MPT
$2.45B
| $4.57M | 0.01% |
348,012
-10,633
| -3% | -$137K |
|
1413
CALL
Everest Group
EG
$14.4B
| $4.57M | 0.01% |
20,000
| – | – |
|
|
ZAYO
1414
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $4.56M | 0.01% |
132,595
-140,563
| -51% | -$4.66M |
|
1415
Liberty Latin America Class A
LILA
$1.69B
| $4.56M | 0.01% |
299,775
| – | – |
|
1416
CALL
Vertex Pharmaceuticals
VRTX
$140B
| $4.56M | 0.01% |
30,000
+20,000
| +200% | +$3.01M |
|
1417
Idexx Laboratories
IDXX
$43.3B
| $4.54M | 0.01% |
29,233
-9,924
| -25% | -$1.57M |
|
1418
Curtiss-Wright
CW
$22.5B
| $4.53M | 0.01% |
43,356
-59,531
| -58% | -$5.78M |
|
1419
Silicon Laboratories
SLAB
$7.29B
| $4.53M | 0.01% |
56,680
+27,959
| +97% | +$2.08M |
|
1420
CNO Financial Group
CNO
$5.01B
| $4.52M | 0.01% |
193,761
-114,603
| -37% | -$2.56M |
|
|
TMHC
1421
DELISTED
Taylor Morrison
TMHC
| $4.51M | 0.01% |
204,654
+118,241
| +137% | +$2.61M |
|
1422
Magnite
MGNI
$3.43B
| $4.5M | 0.01% |
1,158,319
+348,511
| +43% | +$1.48M |
|
|
WCN
1423
Waste Connections
WCN
$41.8B
| $4.5M | 0.01% |
64,255
+11,035
| +21% | +$729K |
|
1424
Skyworks Solutions
SWKS
$9.89B
| $4.49M | 0.01% |
44,100
+13,813
| +46% | +$1.43M |
|
1425
ServiceNow
NOW
$131B
| $4.47M | 0.01% |
190,190
+86,545
| +84% | +$1.92M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.